Skip to content

Author

Eric J. Chow

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Immunotherapy-Based Therapies in Pediatric Hodgkin Lymphoma: Potential to Narrow the Gap in Long-Term Survival.

Pediatric advanced-stage Hodgkin lymphoma (HL) is highly curable, yet survivors treated with historical regimens face substantial late morbidity and excess mortality. Immunotherapy-based frontline therapies improve disease control, but late toxicities remain unknown. We developed a simulation model to project lifetime...

Jenn Rogers, Zachary J. Ward, Angela M. Feraco et al. · 0 citations
Review Aug 2026

Development of a Pediatric Oncology Financial Toxicity Outcome Measure With Content and Face Validity: The Parent-Reported Instrument of Costs and Experiences (PRICE).

A novel caregiver-reported instrument to assess financial toxicity in pediatric oncology settings, with content and face validity, is developed to address a lack of validated outcome measures of financial toxicity in pediatric oncology settings.

Timothy J. D. Ohlsen, Grace Fredman, Jacqueline Burgara et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.